Unique effect of clozapine on adenosine A2A-dopamine D2 receptor heteromerization

Biomed Pharmacother. 2023 Apr:160:114327. doi: 10.1016/j.biopha.2023.114327. Epub 2023 Feb 1.

Abstract

The striatal dopamine D2 receptor (D2R) is generally accepted to be involved in positive symptoms of schizophrenia and is a main target for clinically used antipsychotics. D2R are highly expressed in the striatum, where they form heteromers with the adenosine A2A receptor (A2AR). Changes in the density of A2AR-D2R heteromers have been reported in postmortem tissue from patients with schizophrenia, but the degree to which A2R are involved in schizophrenia and the effect of antipsychotic drugs is unknown. Here, we examine the effect of exposure to three prototypical antipsychotic drugs on A2AR-D2R heteromerization in mammalian cells using a NanoBiT assay. After 16 h of exposure, a significant increase in the density of A2AR-D2R heteromers was found with haloperidol and aripiprazole, but not with clozapine. On the other hand, clozapine, but not haloperidol or aripiprazole, was associated with a significant decrease in A2AR-D2R heteromerization after 2 h of treatment. Computational binding models of these compounds revealed distinctive molecular signatures that explain their different influence on heteromerization. The bulky tricyclic moiety of clozapine displaces TM 5 of D2R, inducing a clash with A2AR, while the extended binding mode of haloperidol and aripiprazole stabilizes a specific conformation of the second extracellular loop of D2R that enhances the interaction with A2AR. It is proposed that an increase in A2AR-D2R heteromerization is involved in the extrapyramidal side effects (EPS) of antipsychotics and that the specific clozapine-mediated destabilization of A2AR-D2R heteromerization can explain its low EPS liability.

Keywords: Adenosine A(2A) receptor; Aripiprazole; Clozapine; Dopamine D(2) receptor; Haloperidol; Receptor heteromerization.

MeSH terms

  • Adenosine / pharmacology
  • Animals
  • Antipsychotic Agents* / pharmacology
  • Aripiprazole
  • Clozapine* / pharmacology
  • Dopamine
  • Humans
  • Mammals
  • Receptors, Dopamine D2 / metabolism

Substances

  • Dopamine
  • Clozapine
  • Antipsychotic Agents
  • Receptors, Dopamine D2
  • Aripiprazole
  • Adenosine